首页> 外文期刊>BMC research notes >Chiropractic spinal manipulative therapy for cervicogenic headache: a single-blinded, placebo, randomized controlled trial
【24h】

Chiropractic spinal manipulative therapy for cervicogenic headache: a single-blinded, placebo, randomized controlled trial

机译:脊椎推拿手法治疗宫颈源性头痛:单盲,安慰剂,随机对照试验

获取原文
           

摘要

ObjectiveCervicogenic headache is a disabling headache where pharmacological management have limited effect. Thus, non-pharmacological management is warranted. Our objective was therefore to investigate the efficacy of chiropractic spinal manipulative therapy versus placebo (sham manipulation) and control (continued usual but non-manual management) for cervicogenic headache in a prospective 3-armed single-blinded, placebo, randomized controlled trial of 17?months’ duration. ResultsNineteen participants were equally randomized into the three groups, and 12 participants completed the randomized controlled trial. Headache frequency improved at all time points in the chiropractic spinal manipulative therapy and the placebo group. Headache index improved in the chiropractic spinal manipulative therapy group at all time points, while it improved at 6 and 12?months’ follow-up in the placebo group. The control group remained unchanged during the whole study period. Adverse events were few, mild and transient. Blinding was concealed throughout the RCT. Thus, our results suggest that manual-therapy might be a safe treatment option for participants with cervicogenic headache, but data need to be confirmed in a randomized controlled trial with sufficient sample size and statistical power. Trial registration ClinicalTrials.gov identifier: NCT01687881, 11 September 2012
机译:目的颈源性头痛是一种致残性头痛,其药理管理作用有限。因此,必须进行非药物治疗。因此,我们的目标是在一项前瞻性3臂单盲,安慰剂随机对照试验中,研究脊骨推拿手法治疗与安慰剂(假手术)和对照(持续进行常规治疗,但非人工治疗)对宫颈源性头痛的疗效,共17项几个月的持续时间。结果将19名参与者平均分为3组,其中12名参与者完成了随机对照试验。在脊椎整脊手法治疗和安慰剂组中,头痛频率在所有时间点均得到改善。脊椎推拿手法治疗组的头痛指数在所有时间点均得到改善,而安慰剂组在随访的6和12个月时头痛指数有所改善。对照组在整个研究期间保持不变。不良事件很少,轻微和短暂的。在整个RCT中都隐藏了盲区。因此,我们的结果表明,对于患有宫颈源性头痛的参与者,手动治疗可能是一种安全的治疗方法,但是需要在具有足够样本量和统计能力的随机对照试验中确认数据。试验注册ClinicalTrials.gov标识符:NCT01687881,2012年9月11日

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号